Phase 2 Newly Diagnosed Multiple Myeloma Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Horizon Two: HR NDMM (MMRC-100)
High Risk Newly Diagnosed Multiple Myeloma
Multiple Myeloma Research Consortium300 enrolled7 locationsNCT07053436
Recruiting
Phase 2
18F-Fluciclovine PET/CT in Multiple Myeloma
Multiple MyelomaNewly Diagnosed Multiple Myeloma (NDMM)Relapsed and/or Refractory Multiple Myeloma (RRMM)
National Cancer Institute (NCI)60 enrolled1 locationNCT06103838
Recruiting
Phase 2Phase 3
Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients
Newly Diagnosed Multiple Myeloma
University Hopsital Schleswig Holstein Campus Lübeck100 enrolled6 locationsNCT05665140
Recruiting
Phase 2Phase 3
Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation
Newly Diagnosed Multiple Myeloma
Jinling Hospital, China80 enrolled1 locationNCT06324266